Trial · NCT04475588
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | One-month Mortality Rate Between the Two Arms | One-month | participants | NUMBER | |
| PRIMARY | Lung Function Assessment - Proportion of the Patients With Stable or Improved SpO2 Without Increasing FiO2 | Day 7, Day 14, Day 21 & Day 30 | Patients improved/ weaned off O2, the observation was carried forward | participants | NUMBER |
| PRIMARY | Endo-tracheal Intubation/Invasive Mechanical Ventilation (IMV) | Day 30 | participants | NUMBER | |
| PRIMARY | Reduction in Proportion of Patients on Non-invasive Ventilation | Baseline (Day 1), Day 7, Day 14 Day 21 & Day 30 | participants | NUMBER | |
| PRIMARY | Lung Function Assessment - Proportion of Patients With Stable PaO2 Without Increasing FiO2 | Day 7, Day14, Day 21 & Day30 | Patients improved/ weaned off O2, the observation was carried forward. | participants | NUMBER |
| PRIMARY | Reduction in Proportion of Patients- Invasive Mechanical Ventilation | Day7, Day14, Day21 & Day 30 | There were no patients on invasive mechanical ventilation at baseline | ||
| PRIMARY | Reduction in Proportion of Patients-High Flow Nasal Oxygen | Day7 ,Day 14 ,Day 21, Day 30 | There were no patients on High Flow Nasal Oxygen at baseline | ||
| PRIMARY | Mean Change From Baseline in Ferritin | Day 7, Day 14, Day 21 & Day 30 | only observed values were used. | ng/mL | MEAN |
| PRIMARY | Mean Change From Baseline in LDH | Day 7, Day14, Day 21 and Day 30. | Only observed values were used. | U/L | MEAN |
| PRIMARY | Mean Change From Baseline in CRP (C-reactive Protein) | Day 7, Day 14, Day 21 & Day 30 | Only observed values were used. | mg/L | MEAN |
| PRIMARY | Mean Change From Baseline D-Dimer | Day 7, Day 14, Day 21 & Day 30 | Only observed values were used. | µg/ml | MEAN |
| SECONDARY | Mean Change From Baseline of Absolute Lymphocyte Count | day 7, day 14 ,day 21 & day 30 | Only observed values were used. | cells/mm^3 | MEAN |
| SECONDARY | Biomarkers (IL-6, TNF-a) | Pre and Post 1st dose; Pre and Post 2nd dose | Only observed values were used. | pg/ml | MEAN |
| SECONDARY | Mean PaO2 (Partial Pressure of Oxygen) / FiO2 (Fraction of Inspired Oxygen, FiO2) Ratio (or P/F Ratio) | Baseline, Day 7, Day 14, Day 21 & Day 30 | Only observed values were used. | Ratio | MEAN |
| SECONDARY | Number and Percentage of Patients With Radiological Response | up to Day 30 | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04475588/outcomes